0001911476-22-000001.txt : 20220222 0001911476-22-000001.hdr.sgml : 20220222 20220218182552 ACCESSION NUMBER: 0001911476-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220218 EFFECTIVENESS DATE: 20220222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Psammiad Therapeutics, Inc. CENTRAL INDEX KEY: 0001911476 IRS NUMBER: 853485833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-434323 FILM NUMBER: 22654368 BUSINESS ADDRESS: STREET 1: 700 COLORADO BLVD, SUITE #118 CITY: DENVER STATE: CO ZIP: 80206 BUSINESS PHONE: 720.820.0005 MAIL ADDRESS: STREET 1: 700 COLORADO BLVD, SUITE #118 CITY: DENVER STATE: CO ZIP: 80206 D 1 primary_doc.xml X0708 D LIVE 0001911476 Psammiad Therapeutics, Inc. 700 COLORADO BLVD, SUITE #118 DENVER CO COLORADO 80206 720.820.0005 DELAWARE None None Corporation true 2022 Anthony Gerber 700 Colorado Blvd, Suite 118 Denver CO COLORADO 80206 Executive Officer Director Michael Eber 700 Colorado Blvd, Suite 119 Denver CO COLORADO 80206 Executive Officer Matthew Veatch 700 Colorado Blvd, Suite 119 Denver CO COLORADO 80206 Executive Officer Biotechnology No Revenues 06b false 2022-01-31 false true Convertible Note false 10000 3000000 2200000 800000 false 5 0 0 0 true false Psammiad Therapeutics, Inc. Michael Eber Michael Eber Treasurer 2022-02-18